The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) are to share work on inspections of manufacturing sites in each other's territories, starting in January 2012. The initiative builds on a pilot programme which ran earlier this year. Initially the programme will focus on inspections of manufacturing sites in the EU or US that are already known to the two authorities and have a history of compliance with GMP following previous inspections.
InPharm
Tuesday, 13 December 2011
EMA and FDA to collaborate on GMP inspections
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment